How have GRPH shares performed in 2024?

Graphite Bio's stock was trading at $18.34 on January 1st, 2024. Since then, GRPH stock has decreased by 82.7% and is now trading at $3.18. View the best growth stocks for 2024 here .

How were Graphite Bio's earnings last quarter?

Graphite Bio, Inc. (NASDAQ:GRPH) released its quarterly earnings results on Monday, March, 20th. The company reported ($3.08) EPS for the quarter, topping analysts' consensus estimates of ($3.43) by $0.35.

How often does Graphite Bio pay dividends? What is the dividend yield for Graphite Bio?

Graphite Bio announced a dividend on Friday, March 15th. Shareholders of record on Monday, March 18th will be given a dividend of $7.21 per share on Thursday, March 21st. This represents a yield of 28.93%. The ex-dividend date is Friday, March 15th. Read our dividend analysis for GRPH .

When did Graphite Bio's stock split?

Shares of Graphite Bio reverse split before market open on Friday, March 22nd 2024. The 1-7 reverse split was announced on Friday, March 22nd 2024. The number of shares owned by shareholders was adjusted after the closing bell on Friday, March 22nd 2024. An investor that had 100 shares of stock prior to the reverse split would have 14 shares after the split.

When did Graphite Bio IPO?

Graphite Bio (GRPH) raised $224 million in an initial public offering on Friday, June 25th 2021. The company issued 14,000,000 shares at a price of $15.00-$17.00 per share.

How do I buy shares of Graphite Bio?

Shares of GRPH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here .

NASDAQ:GRPH

Graphite Bio (GRPH) Stock Price, News & Analysis

→ The “Perfect Storm” for Gold (From Gold Safe Exchange) (Ad)

Free GRPH Stock Alerts

$3.18

-0.09 (-2.75%)

(As of 03/21/2024)

Compare

Today's Range: $3.05
▼
$3.23
50-Day Range: $3.18
▼
$26.11
52-Week Range: $2.01
▼
$4.26

Volume: 328,300 shs
Average Volume: 282,405 shs
Market Capitalization: $185.20 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

Get Graphite Bio alerts:

Ad DTI

Biden’s $374B Giveaway Into This Sector

Biden’s Climate Bill Could Send Your Retirement Accounts Soaring – Or Diving See what this $374B giveaway could mean for your retirement right here

Click here for the full story

About Graphite Bio Stock (NASDAQ:GRPH)

Graphite Bio, Inc., a clinical-stage gene editing company, engages in developing therapies for serious and life-threatening diseases in the United States. The company offers GPH102 for the treatment of beta-thalassemia; and GPH201 for the treatment of XSCID, a life-threatening disease for multiple mutations in a single gene. It also offers GPH301, a product candidate for the treatment of Gaucher disease, a genetic disorder that results in a deficiency in the glucocerebrosidase enzyme. The company was formerly known as Integral Medicines, Inc., and changed its name to Graphite Bio, Inc. in August 2020. Graphite Bio, Inc. was incorporated in 2017 and is based in South San Francisco, California.

GRPH Stock Price History

30 days | 90 days | 365 days | Advanced Chart

GRPH Stock News Headlines

April 11, 2024 | americanbankingnews.com

Graphite Bio (NASDAQ:GRPH) Trading Down 2.8%

March 21, 2024 | finance.yahoo.com

LENZ Therapeutics Announces Completion of Merger with Graphite Bio and Provides Update on Recent Clinical and Corporate Progress

April 20, 2024 | DTI (Ad)

Biden’s $374B Giveaway Into This Sector

Biden’s Climate Bill Could Send Your Retirement Accounts Soaring – Or Diving See what this $374B giveaway could mean for your retirement right here

March 15, 2024 | finance.yahoo.com

GRPH Mar 2024 5.000 put

March 15, 2024 | seekingalpha.com

VERI, STI and VERB among mid-day movers

March 15, 2024 | finance.yahoo.com

GRPH Mar 2024 7.500 call

March 14, 2024 | finance.yahoo.com

Graphite Bio, Inc. (GRPH)

March 10, 2024 | marketwatch.com

Graphite Bio to Pay Special Dividend Linked to Lenz Therapeutics Merger

April 20, 2024 | DTI (Ad)

Biden’s $374B Giveaway Into This Sector

Biden’s Climate Bill Could Send Your Retirement Accounts Soaring – Or Diving See what this $374B giveaway could mean for your retirement right here

March 8, 2024 | au.investing.com

Graphite Bio announces $1.03 per share special dividend

March 8, 2024 | msn.com

Graphite Bio declares special $1.03 dividend

March 8, 2024 | businesswire.com

Graphite Bio Declares Special Dividend In Connection with Proposed Merger with Lenz Therapeutics

February 27, 2024 | businesswire.com

GRAPHITE BIO INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Graphite Bio, Inc. - GRPH

February 2, 2024 | markets.businessinsider.com

SHAREHOLDER NOTICE: Brodsky & Smith Announces an Investigation of Graphite Bio, Inc. (GRPH)

December 25, 2023 | seekingalpha.com

Graphite Bio: Reverse Merger Leading Into Big Special Dividend And Q2 Phase 3 Trial

November 27, 2023 | msn.com

Graphite Bio (GRPH) Price Target Increased by 40.00% to 7.14

November 17, 2023 | businesswire.com

GRAPHITE BIO INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Graphite Bio, Inc. - GRPH

November 17, 2023 | businesswire.com

GRAPHITE BIO INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Graphite Bio, Inc. - GRPH

November 16, 2023 | benzinga.com

Shareholder Alert: Ademi LLP investigates whether Graphite Bio, Inc. has obtained a Fair Price in its transaction with LENZ Therapeutics

November 16, 2023 | bizjournals.com

Shattered dream of sickle cell disease cure to end in reverse merger for Peninsula biotech

November 16, 2023 | finance.yahoo.com

What Makes Graphite Bio, Inc. (GRPH) a New Buy Stock

November 15, 2023 | benzinga.com

GRPH Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Graphite Bio, Inc. Is Fair to Shareholders

November 15, 2023 | markets.businessinsider.com

Graphite Bio To Merge With LENZ Therapeutics; Stock Down In Pre-market

November 15, 2023 | finance.yahoo.com

LENZ Therapeutics and Graphite Bio Announce Merger Agreement

November 9, 2023 | morningstar.com

Graphite Bio Inc GRPH

November 1, 2023 | msn.com

Graphite Bio (GRPH) Price Target Increased by 25.00% to 5.10

October 5, 2023 | msn.com

Graphite Bio (GRPH) Price Target Increased by 11.11% to 4.08

See More Headlines

Receive GRPH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Graphite Bio and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings: 3/20/2023
Ex-Dividend for 3/21 Dividend: 3/15/2024
Dividend Payable: 3/21/2024
Today: 4/19/2024
Fiscal Year End: 12/31/2024

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Sector: Medical
Industry: Biological products, except diagnostic
Sub-Industry: N/A
Current Symbol: NASDAQ:GRPH
CUSIP: N/A
CIK: 1815776
Web: www.graphitebio.com
Phone: 650-484-0886
Fax: N/A
Employees: 6
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): ($2.23)
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: $-124,650,000.00
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: -33.12%
Return on Assets: -27.96%

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: 39.20
Quick Ratio: 39.20

Sales & Book Value

Annual Sales: N/A
Price / Sales: N/A
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: $3.15 per share
Price / Book: 1.01

Miscellaneous

Outstanding Shares: 58,240,000
Free Float: 35,874,000
Market Cap: $185.20 million
Optionable: Not Optionable
Beta: 0.20

7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google

Growth stocks offer a lot of bang for your buck, and we've got the next upcoming superstars to strongly consider for your portfolio.

Get This Free Report

Key Executives

Dr. Matthew Porteus M.D. (Age 58)
Ph.D., Academic Founder & Director
Comp: $110k
Stephanie Yao
Vice President of Communications & Investor Relations
Dr. Christine Garrett P.M.P. (Age 53)
Ph.D., Chief Strategy Officer

Key Competitors

View All Competitors

Institutional Ownership

View All Institutional Transactions

GRPH Stock Analysis - Frequently Asked Questions

How have GRPH shares performed in 2024?: Graphite Bio's stock was trading at $18.34 on January 1st, 2024. Since then, GRPH stock has decreased by 82.7% and is now trading at $3.18.
View the best growth stocks for 2024 here.
How were Graphite Bio's earnings last quarter?: Graphite Bio, Inc. (NASDAQ:GRPH) released its quarterly earnings results on Monday, March, 20th. The company reported ($3.08) EPS for the quarter, topping analysts' consensus estimates of ($3.43) by $0.35.
How often does Graphite Bio pay dividends? What is the dividend yield for Graphite Bio?: Graphite Bio announced a dividend on Friday, March 15th. Shareholders of record on Monday, March 18th will be given a dividend of $7.21 per share on Thursday, March 21st. This represents a yield of 28.93%. The ex-dividend date is Friday, March 15th.
Read our dividend analysis for GRPH.
When did Graphite Bio's stock split?: Shares of Graphite Bio reverse split before market open on Friday, March 22nd 2024. The 1-7 reverse split was announced on Friday, March 22nd 2024. The number of shares owned by shareholders was adjusted after the closing bell on Friday, March 22nd 2024. An investor that had 100 shares of stock prior to the reverse split would have 14 shares after the split.

When did Graphite Bio IPO?: Graphite Bio (GRPH) raised $224 million in an initial public offering on Friday, June 25th 2021. The company issued 14,000,000 shares at a price of $15.00-$17.00 per share.
How do I buy shares of Graphite Bio?: Shares of GRPH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:GRPH) was last updated on 4/20/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Graphite Bio (GRPH) Stock Price, News & Analysis

About Graphite Bio Stock (NASDAQ:GRPH)

GRPH Stock Price History

GRPH Stock News Headlines

Company Calendar

Industry, Sector and Symbol

Profitability

Debt

Sales & Book Value

Miscellaneous

Key Executives

Key Competitors

Institutional Ownership

GRPH Stock Analysis - Frequently Asked Questions

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info